Cell Source, Inc. financial data

Symbol
CLCS on OTC
Location
New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity -101 % +0.73%
Return On Equity 30.5 % -21.4%
Return On Assets -2.15K % -20.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43.5M shares +13.8%
Common Stock, Shares, Outstanding 43.3M shares +12.4%
Common Stock, Value, Issued 43.3K USD +12.4%
Weighted Average Number of Shares Outstanding, Basic 42.4M shares +11.1%
Weighted Average Number of Shares Outstanding, Diluted 42.4M shares +11.1%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 2.13M USD -21.1%
Operating Income (Loss) -4.17M USD +4.94%
Nonoperating Income (Expense) -1.06M USD +13.2%
Net Income (Loss) Attributable to Parent -5.23M USD +6.73%
Earnings Per Share, Basic 0 USD/shares +11.1%
Earnings Per Share, Diluted 0 USD/shares +11.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 22K USD +747%
Other Assets, Current 543 USD -84%
Assets 265K USD +6.56%
Accounts Payable, Current 2.04M USD +28.8%
Liabilities 19.2M USD +18%
Retained Earnings (Accumulated Deficit) -45.8M USD -12.9%
Stockholders' Equity Attributable to Parent -18.9M USD -18.2%
Liabilities and Equity 265K USD +6.56%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -174K USD +43.8%
Net Cash Provided by (Used in) Financing Activities 152K USD -31%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 43.3M shares +12.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -22.2K USD +75.3%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 23K USD +790%
Deferred Tax Assets, Valuation Allowance 11.8M USD +14.4%
Deferred Tax Assets, Gross 11.8M USD +14.4%
Deferred Tax Assets, Operating Loss Carryforwards 10M USD +10.2%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 26.9M USD +9.43%
Share-based Payment Arrangement, Expense 289K USD -12.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%